Strain level variation in Proteus mirabilis chondroitin sulfate degradation kinetics and regulation by urea

This study reveals that *Proteus mirabilis* strains exhibit significant variation in chondroitin sulfate degradation kinetics and regulation, with urea repressing this process in specific strains via urease activity and unique endolyase mutations, ultimately diminishing the contribution of chondroitin sulfate degradation to virulence in a mouse model of catheter-associated urinary tract infection.

The Gist

Imagine your bladder is a high-security fortress. The walls of this fortress are lined with a slippery, protective slime coat called Chondroitin Sulfate (CS). Think of this slime as a "Do Not Enter" sign and a non-stick surface combined; it prevents bad bacteria from grabbing onto the walls and starting an infection.

Now, meet the villain of our story: Proteus mirabilis. This is a sneaky bacterium that loves to cause infections, especially in people with urinary catheters (tubes used to drain the bladder). To invade the fortress, Proteus needs to break through that slippery slime coat.

This research paper is like a detective story where scientists investigate how different strains of Proteus try to break that slime coat, and why some are better at it than others. Here is the breakdown in simple terms:

1. The "Slime-Eating" Superpower

The scientists discovered that Proteus has a special set of molecular "scissors" (enzymes) that can cut up the Chondroitin Sulfate slime. Once the slime is cut, the bacteria can eat the pieces for energy and, more importantly, stick to the bladder wall to cause an infection.

2. Not All Villains Are Created Equal

The researchers tested six different strains of Proteus (like testing six different versions of a video game character). They found a huge difference in how fast they could cut the slime:

• The Speedsters: Some strains were like hungry wolves, eating the slime almost immediately.
• The Slow Pokes: One specific strain, named Pm123, was incredibly slow. It took its time, almost like it was waiting for the right moment to strike.

3. The "Urea" Trap (The Plot Twist)

Here is where it gets interesting. Urine contains a chemical called urea.

• For most Proteus strains, urea is just another part of the environment. They ignore it and keep cutting the slime.
• But for the Pm123 strain, urea acts like a remote control that turns off its slime-cutting scissors. When Pm123 senses urea, it stops working entirely.

Why does this happen?
The scientists found that Pm123 has a tiny, unique "glitch" in its molecular scissors (a couple of letter changes in its DNA code). Because of this glitch, when urea breaks down into ammonia (which makes the urine more alkaline/basic), the scissors get jammed and stop working. It's like trying to cut a cake with a knife that turns into jelly when it touches a specific type of frosting.

4. The "Urease" Connection

The bacteria also have an enzyme called urease that breaks down urea. The scientists found that if they blocked the urease enzyme, the Pm123 strain suddenly started cutting the slime again, even with urea present. This proved that the bacteria isn't just "sensing" urea; the chemical reaction caused by breaking down urea is what actually jams the scissors.

5. Does it Matter for the Infection?

The team tested these bacteria in mice to see how this affects real infections.

• The Fast Strains: When the "Speedster" strains lost their ability to cut the slime, the infection got much worse. They couldn't invade the kidneys or spread as easily. This means cutting the slime is a key weapon for them.
• The Slow Strain (Pm123): When the Pm123 strain lost its ability to cut the slime, it didn't matter. Why? Because in the mouse bladder (which is full of urea), Pm123's scissors were already jammed by the urea anyway. So, whether the scissors were broken or just jammed by urea, the result was the same: no slime cutting, and no extra help in causing a severe infection.

The Big Takeaway

This study teaches us that bacteria aren't all the same. Even within the same species, one strain might be a "speed demon" that ignores urine chemistry, while another is a "slowpoke" that gets confused by it.

The Analogy:
Imagine two burglars trying to break into a house with a sticky security gel on the door.

• Burglar A has a laser cutter that works in any weather. They slice through the gel instantly and get in.
• Burglar B has a laser cutter that only works if the air is dry. If it's humid (like in a bathroom with urea), their laser fizzles out.

The scientists found that in a humid environment (the bladder), Burglar B is useless because their tool is broken by the humidity. But Burglar A is still a huge threat. Understanding these differences helps doctors figure out which strains are the most dangerous and how to stop them.

In short: Proteus bacteria can eat the bladder's protective slime, but some strains get "confused" by urea in the urine and stop working. This variation changes how dangerous the infection becomes, which is crucial for treating patients with catheter-associated infections.

Technical Summary

1. Problem Statement

• Context: Urinary tract infections (UTIs), particularly catheter-associated UTIs (CAUTIs), are a major cause of hospital-acquired infections. Proteus mirabilis is a leading pathogen in CAUTIs, known for its swarming motility and urease activity (which causes catheter encrustation).
• The Gap: The bladder urothelium is coated with a glycosaminoglycan (GAG) layer, primarily chondroitin sulfate (CS), which acts as a physical barrier against pathogen adherence. While P. mirabilis was previously shown to degrade CS, the kinetics, regulation, and strain-level diversity of this degradation were unknown. Furthermore, it was unclear if CS degradation is a conserved virulence mechanism across clinical isolates or if it is regulated by urinary components like urea.

2. Methodology

The study employed a multi-faceted approach combining genomics, microbiology, biochemistry, and in vivo modeling:

• Strain Collection & Genomics: Six clinical P. mirabilis isolates were obtained from postmenopausal women (with recurrent UTI history or active infection) at UT Southwestern. These were sequenced (Illumina + Nanopore) and assembled. A phylogenetic tree was constructed using 584 publicly available P. mirabilis genomes to contextualize the new isolates. Antibiotic resistance genes (ARGs) were annotated using ResFinder.
• Degradation Assays: Semi-quantitative GAG degradation assays were performed in various media:
  • M9Ypm: Minimal media with yeast extract.
  • LB: Rich media.
  • AUM: Artificial Urine Media (containing urea).
  • Variations: Media were modified with/without urea, glucose, or the urease inhibitor acetohydroxamic acid (AHA).
• Genetic Manipulation:
  • Knockouts: Markerless double deletions of the putative chondroitinase genes (chABCI endolyase and chABCII exolyase) were generated in strains Pm123, Pm1668, and Pm1673 using the pDM4 vector and sacB selection.
  • Complementation: The chABCI gene from Pm123 and the type strain HI4320 were cloned into a double-knockout background of HI4320 to test for functional differences.
• Molecular Analysis:
  • RT-qPCR: Measured expression of chABCI and chABCII in the presence/absence of urea and CS.
  • Structural Modeling: AlphaFold 3 was used to predict 3D structures of the enzymes, followed by structural alignment to identify unique mutations in the Pm123 enzyme.
• Phenotypic Assays:
  • Urease Activity: Measured via phenol-red pH assay.
  • Swarming Motility: Measured on semi-solid agar with/without urea.
  • Antibiotic Susceptibility: MIC determination for various antibiotics.
• In Vivo Model: A murine CAUTI model using female CBA/J mice with indwelling catheters. Mice were infected with wild-type and double-knockout strains of Pm123 (urea-sensitive) and Pm1673 (urea-insensitive). Bacterial loads (CFU) in urine, bladder, kidney, and spleen were measured at 48 hours.

3. Key Contributions

• Strain-Level Diversity: Demonstrated that CS degradation kinetics vary significantly among clinical P. mirabilis strains, categorizing them into "fast," "moderate," and "slow" degraders.
• Urea Repression Mechanism: Discovered a novel regulatory mechanism where urea represses CS degradation in specific strains (e.g., Pm123) via a urease-dependent pathway.
• Enzyme Variability: Identified that the repression is not due to gene expression changes but rather structural/functional differences in the ChABCI endolyase enzyme. Two unique point mutations (T231K and D416E) in the Pm123 enzyme were identified as potential causes of urea sensitivity.
• Virulence Context: Showed that the contribution of CS degradation to virulence is strain-dependent. In urea-insensitive strains, CS degradation aids in ascending infection; in urea-sensitive strains, the high urea environment of the bladder naturally suppresses this activity, rendering the enzyme non-essential for virulence in that specific host context.

4. Key Results

• Kinetics Variation: In minimal media (M9Ypm), strains Pm493 and Pm1325 were "fast" degraders (degraded CS in <8 hrs), HI4320 and Pm1673 were "moderate," and Pm123 was "slow" (significant degradation only after 24 hrs).
• Urea Effect:
  • In Artificial Urine Media (AUM), Pm123 failed to degrade CS, whereas other strains succeeded.
  • Removing urea from AUM restored Pm123's ability to degrade CS.
  • Adding urea to minimal media (M9Ypm) or rich media (LB) completely inhibited CS degradation in Pm123 but not in other strains.
• Mechanism of Repression:
  • Not Transcriptional: RT-qPCR showed no significant change in chABCI expression upon urea exposure.
  • Urease Dependent: Inhibiting urease with AHA restored CS degradation in Pm123 even in the presence of urea. This suggests urea breakdown products (ammonia/high pH) inhibit the enzyme.
  • Enzyme Specificity: Cross-complementation showed that expressing the Pm123 chABCI gene in a urea-insensitive background (HI4320) conferred urea sensitivity. Structural modeling revealed Pm123 ChABCI has unique mutations (T231K in the sugar-binding domain; D416E in the catalytic domain) likely affecting stability or substrate binding at high pH.
• Virulence Outcomes:
  • Pm1673 (Urea-insensitive): Loss of chondroitinase activity significantly reduced kidney and spleen colonization and weight loss, indicating CS degradation is a virulence factor.
  • Pm123 (Urea-sensitive): No significant difference in virulence between wild-type and knockout strains. The authors hypothesize that the high urea concentration in mouse urine (~1,800 mmol/L) naturally inhibits the Pm123 enzyme, making the knockout phenotype indistinguishable from the wild-type.
• Antibiotic Resistance: Pm123 was an outlier, showing resistance to nearly all tested antibiotics (except meropenem) and possessing the highest number of ARGs. It also exhibited a swarming defect.

5. Significance

• Clinical Relevance: This study highlights that virulence mechanisms in P. mirabilis are not uniform across clinical isolates. The ability to degrade host barriers (CS) is a conserved trait but is differentially regulated, which impacts how different strains cause disease.
• Regulatory Insight: The discovery that urea (a major urinary component) can repress virulence factors via urease activity provides a new perspective on host-pathogen interactions. It suggests that the urinary environment itself can modulate bacterial virulence strategies.
• Therapeutic Implications: Understanding that CS degradation is strain-specific and regulated by urea could inform the development of targeted therapies. For instance, in urea-sensitive strains, the enzyme is naturally suppressed in the bladder, potentially reducing the need for direct inhibition, whereas urea-insensitive strains may require specific chondroitinase inhibitors to prevent ascending infection.
• Evolutionary Trade-off: The correlation between the swarming defect, high antibiotic resistance, and urea sensitivity in Pm123 suggests a potential evolutionary trade-off between motility, resistance, and metabolic regulation in specific clinical niches.